Epidarex Capital Partners Limited (formerly Rock Spring Ventures) is an Edinburgh based venture capital firm investing in the life sciences and health technology sector in United States and United Kingdom. It prefers innovations from the educational sectors like universities. The company focuses on biotechnology, medical devices and pharmaceuticals, personalized medicine and diagnostics, and healthcare IT and services. As of 2019, the company has invested 23 times in 12 portfolio companies with three successful exits.
Edinburgh Molecular Imaging Limited is an Edinburgh-based developer of optical molecular imaging technology.
Macomics is an Edinburgh-based immuno-oncology company.